Polysaccharide-specific B cell responses to vaccination in humans

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 6, 2014, Pages 1661-1668

  Mitchell, Ruth ^a   Kelly, Dominic F ^a   Pollard, Andrew J ^a   Trück, Johannes ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antibody; B cells; B lymphocytes; Glycoconjugate; Immune response; Polysaccharide; Thymus dependent; Thymus independent; Vaccination

Indexed keywords

BACTERIAL POLYSACCHARIDE; GLYCOCONJUGATE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; BACTERIAL VACCINE; BACTERIUM ANTIBODY;

ACTIVE IMMUNIZATION; ANTIBODY RESPONSE; ANTIBODY TITER; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL KINETICS; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; MENINGOCOCCOSIS; NOTE; PLASMA CELL; PNEUMOCOCCAL INFECTION; ADOLESCENT; ADULT; AGED; BLOOD; CHILD; FEMALE; HAEMOPHILUS INFLUENZAE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFANT; MALE; NEISSERIA MENINGITIDIS; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; B-LYMPHOCYTE SUBSETS; BACTERIAL VACCINES; CHILD; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; IMMUNOLOGIC MEMORY; INFANT; MALE; NEISSERIA MENINGITIDIS; PLASMA CELLS; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE;

EID: 84903549210     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.28350     Document Type: Note

References (49)

1. Watt JP, Wolfson LJ, O'Brien KL, Henkle E, Deloria-Knoll M, McCall N, Lee E, Levine OS, Hajjeh R, Mulholland K, et al.; Hib and Pneumococcal Global Burden of Disease Study Team. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 2009; 374:903-11; PMID:19748399; http://dx.doi.org/10.1016/S0140-6736(09)61203-4
2. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T; Hib and Pneumococcal Global Burden of Disease Study Team. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374:893-902; PMID:19748398; http://dx.doi.org/10.1016/S0140-6736(09)61204-6
3. Khatami A, Pollard AJ. The epidemiology of meningococcal disease and the impact of vaccines. Expert Rev Vaccines 2010; 9:285-98; PMID:20218857; http://dx.doi.org/10.1586/erv.10.3
4. Blanchard-Rohner G, Pollard AJ. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy. Expert Rev Vaccines 2011; 10:673-84; PMID:21604987; http://dx.doi.org/10.1586/erv.11.14
5. Blanchard Rohner G, Snape MD, Kelly DF, John T, Morant A, Yu LM, Borkowski A, Ceddia F, Borrow R, Siegrist CA, et al. The magnitude of the antibody and memory B cell responses during priming with a protein- polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response. J Immunol 2008; 180:2165-73; PMID:18250423
6. Clutterbuck EA, Salt P, Oh S, Marchant A, Beverley P, Pollard AJ. The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine. Immunology 2006; 119:328-37; PMID:17067312; http://dx.doi.org/10.1111/j.1365-2567.2006.02436.x
7. Kelly DF, Snape MD, Clutterbuck EA, Green S, Snowden C, Diggle L, Yu LM, Borkowski A, Moxon ER, Pollard AJ. CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. Blood 2006; 108:2642-7; PMID:16675705; http://dx.doi.org/10.1182/blood-2006-01-009282
8. Kelly DF, Snape MD, Perrett KP, Clutterbuck EA, Lewis S, Blanchard Rohner G, Jones M, Yu LM, Pollard AJ. Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine. Immunology 2009; 127:134-43; PMID:19175802; http://dx.doi.org/10.1111/j.1365-2567.2008.02934.x
9. Perrett KP, Jin C, Clutterbuck E, John TM, Winter AP, Kibwana E, Yu LM, Curtis N, Pollard AJ. B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody. J Immunol 2012; 189:2673-81; PMID:22855707; http://dx.doi.org/10.4049/ jimmunol.1200451
10. Clutterbuck EA, Oh S, Hamaluba M, Westcar S, Beverley PC, Pollard AJ. Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine. Clin Vaccine Immunol 2008; 15:182-93; PMID:18032593; http://dx.doi.org/10.1128/CVI.00336-07
11. Blanchard-Rohner G, Snape MD, Kelly DF, O'Connor D, John T, Clutterbuck EA, Ohene-Kena B, Klinger CL, Odrljin T, Pollard AJ. The B-cell response to a primary and booster course of MenACWY-CRM197 vaccine administered at 2, 4 and 12 months of age. Vaccine 2013; 31:2441-8; PMID:23566945; http://dx.doi.org/10. 1016/j.vaccine.2013.03.036
12. Blanchard-Rohner G, Pulickal AS, Jol-van der Zijde CM, Snape MD, Pollard AJ. Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans. Blood 2009; 114:4998-5002; PMID:19843885; http://dx.doi.org/10.1182/blood-2009-03-211052
13. Baxendale HE, Keating SM, Johnson M, Southern J, Miller E, Goldblatt D. The early kinetics of circulating pneumococcal-specific memory B cells following pneumococcal conjugate and plain polysaccharide vaccines in the elderly. Vaccine 2010; 28:4763-70; PMID:20471437; http://dx.doi.org/10.1016/j.vaccine. 2010.04.103
14. Henneken M, Burdin N, Thoroddsen E, Sigurdardottir ST, Trannoy E, Jonsdottir I. Meningococcal serogroup C polysaccharide specific memory B cells, directly enumerated by labeled polysaccharide, are not affected by age at vaccination. Vaccine 2010; 28:2097-103; PMID:20056181; http://dx.doi.org/10. 1016/j.vaccine.2009.12.039
15. Khaskhely N, Mosakowski J, Thompson RS, Khuder S, Smithson SL, Westerink MA. Phenotypic analysis of pneumococcal polysaccharide-specific B cells. J Immunol 2012; 188:2455-63; PMID:22271652; http://dx.doi.org/10.4049/jimmunol. 1102809
16. Liu YJ, Zhang J, Lane PJ, Chan EY, MacLennan IC. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol 1991; 21:2951-62; PMID:1748148; http://dx.doi.org/10.1002/eji.1830211209
17. Halliley JL, Kyu S, Kobie JJ, Walsh EE, Falsey AR, Randall TD, Treanor J, Feng C, Sanz I, Lee FE. Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. Vaccine 2010; 28:3582-7; PMID:20298818; http://dx.doi.org/10.1016/j.vaccine.2010.02.088
18. Sasaki S, He XS, Holmes TH, Dekker CL, Kemble GW, Arvin AM, Greenberg HB. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One 2008; 3:e2975; PMID:18714352; http://dx.doi.org/10.1371/journal.pone. 0002975
19. Cox RJ, Brokstad KA, Zuckerman MA, Wood JM, Haaheim LR, Oxford JS. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 1994; 12:993-9; PMID:7975853; http://dx.doi.org/10.1016/0264-410X(94)90334-4
20. Wickham HW. [Endless loop including component title]. Springer New York; 2009. Available from: http://had.co.nz/ggplot2/book
21. R Core Team. R: A Language and Environment for Statistical Computing [Internet]. R Foundation for Statistical Computing 2013. Available from: http://www.R-project.org/
22. Crotty S, Aubert RD, Glidewell J, Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 2004; 286:111-22; PMID:15087226; http://dx.doi.org/10.1016/j. jim.2003.12.015
23. Blanchard-Rohner G, Galli G, Clutterbuck EA, Pollard AJ. Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in children. J Immunol Methods 2010; 358:46-55; PMID:20361969; http://dx.doi.org/10.1016/j. jim.2010.03.014
24. Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003; 171:4969-73; PMID:14607890
25. Clutterbuck EA, Lazarus R, Yu LM, Bowman J, Bateman EA, Diggle L, Angus B, Peto TE, Beverley PC, Mant D, et al. Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells. J Infect Dis 2012; 205:1408-16; PMID:22457293; http://dx.doi.org/10.1093/infdis/ jis212
26. Defrance T, Taillardet M, Genestier L. T cell-independent B cell memory. Curr Opin Immunol 2011; 23:330-6; PMID:21482090; http://dx.doi.org/10.1016/j. coi.2011.03.004
27. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996; 271:348-50; PMID:8553069; http://dx.doi.org/10.1126/science.271. 5247.348
28. Hostetter MK. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J Infect Dis 1986; 153:682-93; PMID:3950449; http://dx.doi.org/10.1093/infdis/153.4.682
29. Rijkers GT, Sanders EA, Breukels MA, Zegers BJ. Infant B cell responses to polysaccharide determinants. Vaccine 1998; 16:1396-400; PMID:9711778; http://dx.doi.org/10.1016/S0264-410X(98)00098-X
30. Lucas AH, Reason DC. Polysaccharide vaccines as probes of antibody repertoires in man. Immunol Rev 1999; 171:89-104; PMID:10582166; http://dx.doi.org/10.1111/j.1600-065X.1999.tb01343.x
31. Weill JC, Weller S, Reynaud CA. Human marginal zone B cells. Annu Rev Immunol 2009; 27:267-85; PMID:19302041; http://dx.doi.org/10.1146/annurev. immunol.021908.132607
32. Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME, Plebani A, Kumararatne DS, Bonnet D, Tournilhac O, et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004; 104:3647-54; PMID:15191950; http://dx.doi.org/10.1182/blood-2004-01-0346
33. Martin F, Kearney JF. Marginal-zone B cells. Nat Rev Immunol 2002; 2:323-35; PMID:12033738; http://dx.doi.org/10.1038/nri799
34. Kelly DF, Snape MD, Clutterbuck EA, Green S, Snowden C, Diggle L, Yu LM, Borkowski A, Moxon ER, Pollard AJ. CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. Blood 2006; 108:2642-7; PMID:16675705; http://dx.doi.org/10.1182/blood-2006-01-009282
35. Andrews NJ, Waight PA, George RC, Slack MP, Miller E. Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales. Vaccine 2012; 30:6802-8; PMID:23000122; http://dx.doi.org/10.1016/j.vaccine.2012.09.019
36. Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009; 180:48-58; PMID:19124790; http://dx.doi.org/10.1503/cmaj.080734
37. Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008; CD000422; PMID:18253977
38. O'Brien KL, Hochman M, Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? Lancet Infect Dis 2007; 7:597-606; PMID:17714673; http://dx.doi.org/10.1016/S1473- 3099(07)70210-4
39. Lazarus R, Clutterbuck E, Yu LM, Bowman J, Bateman EA, Diggle L, Angus B, Peto TE, Beverley PC, Mant D, et al. A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adults. Clin Infect Dis 2011; 52:736-42; PMID:21367726; http://dx.doi.org/10.1093/cid/cir003
40. Brynjolfsson SF, Henneken M, Bjarnarson SP, Mori E, Del Giudice G, Jonsdottir I. Hyporesponsiveness following booster immunization with bacterial polysaccharides is caused by apoptosis of memory B cells. J Infect Dis 2012; 205:422-30; PMID:22158565; http://dx.doi.org/10.1093/infdis/jir750
41. Leggat DJ, Thompson RS, Khaskhely NM, Iyer AS, Westerink MA. The immune response to pneumococcal polysaccharides 14 and 23F among elderly individuals consists predominantly of switched memory B cells. J Infect Dis 2013; 208:101-8; PMID:23547142; http://dx.doi.org/10.1093/infdis/jit139
42. Iwajomo OH, Finn A, Moons P, Nkhata R, Sepako E, Ogunniyi AD, Williams NA, Heyderman RS. Deteriorating pneumococcal-specific B-cell memory in minimally symptomatic African children with HIV infection. J Infect Dis 2011; 204:534-43; PMID:21791655; http://dx.doi.org/10.1093/infdis/jir316
43. Mitchell R, Trück J, Pollard AJ. Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6-17 years. Expert Opin Biol Ther 2013; 13:1451-65; PMID:23889554; http://dx.doi.org/10.1517/14712598.2013. 824419
44. Manz RA, Hauser AE, Hiepe F, Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol 2005; 23:367-86; PMID:15771575; http://dx.doi.org/10. 1146/annurev.immunol.23.021704.115723
45. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004; 350:2572-81; PMID:15201414; http://dx.doi.org/10.1056/NEJMoa032534
46. Amanna IJ, Slifka MK. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol Rev 2010; 236:125-38; PMID:20636813; http://dx.doi.org/10.1111/j.1600-065X.2010.00912.x
47. Mackay F, Figgett WA, Saulep D, Lepage M, Hibbs ML. B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor. Immunol Rev 2010; 237:205-25; PMID:20727038; http://dx.doi.org/10. 1111/j.1600-065X.2010.00944.x
48. Trück J, Mitchell R, Bowman J, Thompson A, Clutterbuck EA, Snape MD, et al. The memory B cell response to a booster dose of a 13-valent (PCV-13) or 10-valent (PHiD-CV) pneumococcal conjugate vaccine. 31st Annual Meeting of the European Society for Paediatric Infectious Diseases; 2013 May 28-June 1; Milan, Italy.
49. Clarke ET, Williams NA, Dull PM, Findlow J, Borrow R, Finn A, Heyderman RS. Polysaccharide-protein conjugate vaccination induces antibody production but not sustained B-cell memory in the human nasopharyngeal mucosa. Mucosal Immunol 2013; 6:288-96; PMID:22806100; http://dx.doi.org/10.1038/mi.2012.70